Tau PET/CT Imaging in the Mismatch Prospective Cohort Study (MPC-TAU)
Start Date
3/14/2023
Completion Date
12/1/2029
Summary
To collect Tau PET/CT imaging in older adults diagnosed with Mild Cognitive Impairment (MCI) or Alzheimer's Disease (AD) in the Mismatch Prospective Cohort Study (MPC-Tau) study to determine relationship to clinical, cognitive, and other biomarker data. Findings from this study will likely provide insight into the phenotypic variability of Alzheimer's Disease and other related pathologies.
Detailed Description
This is a cross-sectional study using the radiotracer AV-1451 to determine the relationship of tau pathology to other biomarker data of MPC participants. All subjects will already have been enrolled in the MPC Study. For the current protocol, participants will provide informed consent before beginning any study procedures. After screening assessments, participants will undergo PET/CT scan imaging with AV-1451.
Eligibility Criteria
Age Range: 18 years to 120 years
Interventions
AV-1451
Conditions
Locations
Massachusetts General Hospital
Boston, Massachusetts 02114-2696
United States
University of Pennsylvania
Philadelphia, Pennsylvania 19104
United States